Firm at a glance
Eight Roads is a platform private equity firm founded in 1969 with offices across China, Europe & Israel, India, Japan, and the US, per its own website [S1]. The firm reports managing over $5 billion in assets under management [S2].
What they buy
Based on publicly disclosed portfolio holdings, Eight Roads appears to concentrate on technology-enabled businesses spanning enterprise software, fintech, healthcare IT, and pharma & therapeutics sectors [S3]. The firm’s portfolio reflects a global investment mandate with companies operating across multiple continents. Observed investments include both early-stage technology platforms and established consumer-facing businesses, suggesting a flexible approach to company maturity and sector [S3].
Portfolio
Enterprise
AppsFlyer, Icertis, and Asobica [S3].
Fintech
Paidy and Swan [S3].
Healthcare IT & Pharma
Eleos (Healthcare IT), Insilico Medicine (Pharma & Therapeutics), and J-Pharma (Pharma & Therapeutics) [S3].
Consumer & IT
Alibaba (Consumer) and pony.ai (IT) [S3].
Other Portfolio Companies
Shadowfax, SDP Japan, mento, Salowin, Xbit, and WHILL [S3].
Recent activity (last 24 months)
* Salowin acquisition, June 2026 [S4]
* Xbit acquisition, May 2026 [S4]
* J-Pharma exit, March 2026 [S4]
* Shadowfax exit, February 2026 [S4]
* Insilico Medicine exit, December 2025 [S4]
* pony.ai acquisition, July 2025 [S4]
* SDP Japan acquisition, June 2025 [S4]
* mento acquisition, April 2025 [S4]
* Insilico Medicine acquisition, March 2025 [S4]
* Salowin acquisition, February 2025 [S4]
* Swan acquisition, February 2025 [S4]
* Eleos acquisition, January 2025 [S4]
* Fibe acquisition, 2024 [S4]
How this firm fits a seller
Eight Roads demonstrates an active exit track record, with three portfolio company exits completed between December 2025 and March 2026 [S4]. The firm’s global office footprint across five regions suggests capacity to support businesses with international expansion plans or cross-border operations [S1]. For sellers in healthcare IT, enterprise software, or fintech sectors, the firm’s concentration in these areas may indicate relevant operational expertise and network access [S3]. The firm’s transaction pace, with thirteen acquisitions or exits in the trailing 24 months, indicates ongoing deployment activity [S4].
Sources
[S1] https://eightroads.com/en/about (as of 2025-01-15)
[S2] https://eightroads.com (as of 2025-01-15)
[S3] https://eightroads.com/en/companies (as of 2025-01-15)
[S4] https://eightroads.com/en/news (as of 2025-01-15)
Frequently asked questions
Does Eight Roads buy enterprise software businesses?
Yes, per publicly available portfolio information. Eight Roads holds investments in enterprise software companies including AppsFlyer, Icertis, and Asobica [S3]. The firm’s observed sector focus includes enterprise technology alongside fintech and healthcare IT [S3].
What companies has Eight Roads acquired recently?
Recent acquisitions include Xbit in May 2026, Salowin in June 2026, and pony.ai in July 2025 [S4]. The firm also acquired Swan and Eleos in early 2025 [S4].
Where is Eight Roads based and how big is the firm?
Eight Roads maintains offices in China, Europe & Israel, India, Japan, and the US, without a single designated headquarters [S1]. The firm reports managing approximately $5 billion or more in assets under management [S2].
Is Eight Roads still actively acquiring?
Yes, based on recent transaction history. The firm completed acquisitions as recently as June 2026 with Salowin and May 2026 with Xbit [S4]. The firm executed thirteen transactions (acquisitions and exits) in the trailing 24 months through mid-2026 [S4].
This profile is maintained by CT Acquisitions as an independent third-party reference. CT Acquisitions is not affiliated with, endorsed by, or a representative of the firm profiled. All facts sourced from publicly available materials as of the dates cited.